Nick brings over 30 years of experience in fundraising, public markets and private equity, gained through financial and commercial roles in international pharmaceuticals and technology businesses. Nick was formerly CFO at Midatech Pharma PLC (now Biodexa Pharmaceuticals PLC), a listed pharmaceutical business with operations in the UK and Spain. He successfully steered Midatech through its IPO on AIM, a dual listing on NASDAQ and subsequent fundraises. Nick is a Chartered Accountant and holds a BSc in Pharmacology from Bath University and an MBA.